Jeez we're lucky aren't we, thanks for that link GKM:
FDA Pins ANDA Backlog on Inspection Resources, Calls for User Fees
The FDA is telling generic-drug makers that a lack of resources to conduct inspections outside of the U.S. is largely to blame for the agency?s backlog in ANDAs and is urging the industry to accept user fees as a solution the problem. In a speech Thursday at the Generic Pharmaceutical Association annual meeting in Orlando, Deborah Autor, director of the FDA?s Office of Compliance, told drugmakers that the agency currently has 192 foreign generic-drug manufacturing facilities requiring a pre-approval inspection but, because of its limited resources, is only scheduled to conduct 62 of those inspections in fiscal 2011.
- Forums
- ASX - By Stock
- TSN
- every day
every day, page-8
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TSN (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, Managing Director & CEO
Charles Armstrong
Managing Director & CEO
SPONSORED BY The Market Online